Cargando…
Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines
INTRODUCTION: Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) mutations occur in approximately one-third of colorectal (CRC) tumours and have been associated with poor prognosis and resistance to some therapeutics. In addition to the well-documented pro-tumorigenic role of mutant Ras alleles, ther...
Autores principales: | Varshavi, Dorna, Varshavi, Dorsa, McCarthy, Nicola, Veselkov, Kirill, Keun, Hector C., Everett, Jeremy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162829/ https://www.ncbi.nlm.nih.gov/pubmed/32300895 http://dx.doi.org/10.1007/s11306-020-01674-2 |
Ejemplares similares
-
Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
por: Varshavi, Dorna, et al.
Publicado: (2021) -
Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5
(−/−) mice, decreases plasma cholesterol and epididymal fat deposition
por: Veeravalli, Sunil, et al.
Publicado: (2022) -
Metabolic Biomarkers of Ageing in C57BL/6J Wild-Type and Flavin-Containing Monooxygenase 5 (FMO5)-Knockout Mice
por: Varshavi, Dorsa, et al.
Publicado: (2018) -
A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments
por: Dona, Anthony C., et al.
Publicado: (2016) -
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009)